Clinical Validation of Whole Genome Sequencing for Cancer DiagnosticsPaul Roepman, Edwin Cuppen, Ewart de Bruijn et al.|Journal of Molecular Diagnostics|2021Cited by 90
The impact of coding germline variants on contralateral breast cancer risk and survivalAnna Morra, Patricia Harrington, Nasim Mavaddat et al.|The American Journal of Human Genetics|2023Cited by 28
Clinical validation of Whole Genome Sequencing for cancer diagnosticsPaul Roepman, Edwin Cuppen, Ewart de Bruijn et al.|medRxiv|2020Cited by 13
Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European AncestryMartine Dumont, Juliane Ramser, Penny Soucy et al.|Cancers|2022Cited by 5